RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
WuXi Biologics (Cayman) Stock

WuXi Biologics (Cayman) Debt 2024

WuXi Biologics (Cayman) Debt

-5,108.48 CNY

Ticker

2269.HK

ISIN

KYG970081173

WKN

A2QJCN

In 2024, WuXi Biologics (Cayman)'s total debt was -5,108.48 CNY, a 158.85% change from the -1,973.56 CNY total debt recorded in the previous year.

WuXi Biologics (Cayman) Aktienanalyse

What does WuXi Biologics (Cayman) do?

WuXi Biologics (Cayman) Inc. is a company specializing in the development and manufacturing of biopharmaceuticals. It was founded in 2015 and is headquartered in Shanghai, China. WuXi Biologics is the world's largest biologics development and manufacturing services company and is also listed on the Hong Kong Stock Exchange. WuXi Biologics (Cayman) ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding WuXi Biologics (Cayman)'s Debt Structure

WuXi Biologics (Cayman)'s total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing WuXi Biologics (Cayman)'s debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to WuXi Biologics (Cayman)’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in WuXi Biologics (Cayman)’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about WuXi Biologics (Cayman) stock

What is the debt of WuXi Biologics (Cayman) this year?

WuXi Biologics (Cayman) has a debt level of -5,108.48 CNY this year.

What was the debt of WuXi Biologics (Cayman) compared to the previous year?

The debt of WuXi Biologics (Cayman) has increased by 158.85% compared to the previous year increased.

What are the consequences of high debt for investors in WuXi Biologics (Cayman)?

High debt can pose a risk for investors of WuXi Biologics (Cayman), as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of WuXi Biologics (Cayman)?

Low debt means that WuXi Biologics (Cayman) has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from WuXi Biologics (Cayman) affect the company?

An increase in debt of WuXi Biologics (Cayman) can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of WuXi Biologics (Cayman) affect the company?

A reduction in debt of WuXi Biologics (Cayman) can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of WuXi Biologics (Cayman)?

Some factors that can influence the debt of WuXi Biologics (Cayman) include investments, acquisitions, operating costs, and revenue development.

Why are the debts of WuXi Biologics (Cayman) so important for investors?

The debts of WuXi Biologics (Cayman) are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can WuXi Biologics (Cayman) take to change the debt?

To change the debt, WuXi Biologics (Cayman) can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does WuXi Biologics (Cayman) pay?

Over the past 12 months, WuXi Biologics (Cayman) paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, WuXi Biologics (Cayman) is expected to pay a dividend of 0 CNY.

What is the dividend yield of WuXi Biologics (Cayman)?

The current dividend yield of WuXi Biologics (Cayman) is .

When does WuXi Biologics (Cayman) pay dividends?

WuXi Biologics (Cayman) pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of WuXi Biologics (Cayman)?

WuXi Biologics (Cayman) paid dividends every year for the past 0 years.

What is the dividend of WuXi Biologics (Cayman)?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is WuXi Biologics (Cayman) located?

WuXi Biologics (Cayman) is assigned to the 'Health' sector.

Wann musste ich die Aktien von WuXi Biologics (Cayman) kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of WuXi Biologics (Cayman) from 11/20/2024 amounting to 0 CNY, you needed to have the stock in your portfolio before the ex-date on 11/20/2024.

When did WuXi Biologics (Cayman) pay the last dividend?

The last dividend was paid out on 11/20/2024.

What was the dividend of WuXi Biologics (Cayman) in the year 2023?

In the year 2023, WuXi Biologics (Cayman) distributed 0 CNY as dividends.

In which currency does WuXi Biologics (Cayman) pay out the dividend?

The dividends of WuXi Biologics (Cayman) are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von WuXi Biologics (Cayman)

Our stock analysis for WuXi Biologics (Cayman) Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of WuXi Biologics (Cayman) Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.